ARTICLE |
a Subdivision of Neonatology, Department of Pediatrics
c Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands
b Subdivision of Neonatology, Department of Pediatrics, Haga Hospital, Juliana Children's Hospital, The Hague, Netherlands
| ABSTRACT |
|---|
|
|
|---|
METHODS. Infants were randomly assigned within 48 hours of birth to the developmental care group or the standard care control group (no covers or nests). The intervention continued until the infant either was transferred to a regional hospital or was discharged from the hospital. Length, weight, and head circumference were measured (bi)weekly and at term age. Neuromotor development was defined as definitely abnormal (presence of a neonatal neurologic syndrome, such as apathy or hyperexcitability, hypotonia or hypertonia, hyporeflexia or hyperreflexia, hypokinesia or hyperkinesia, or a hemisyndrome), mildly abnormal (presence of only part of such a syndrome), or normal.
RESULTS. A total of 192 infants were included (developmental care: 98; control: 94). Thirteen infants (developmental care: 7; control: 6) were excluded according to protocol (admitted for less than or died within the first 5 days: n = 12; taken out at parents request: n = 1), which left a total of 179 infants who met inclusion criteria. In-hospital mortality was 12 (13.2%) of 91 in the developmental care group and 8 (9.1%) of 88 in the control group. There was no significant difference in the number of days of respiratory support, number of intensive care days, short-term growth, or neuromotor developmental outcome at term age between the developmental care and control groups. Duration of the intervention, whether only during the intensive care period or until hospital discharge, had no significant effect on outcome.
CONCLUSIONS. Providing basic developmental care in the NICU had no effect on short-term physical and neurologic outcomes in infants who were born at <32 weeks gestation.
Key Words: preterm infants developmental care NIDCAP growth respiratory support intensive care neurodevelopment
Abbreviations: DC—developmental care NIDCAP—Newborn Individualized Developmental Care and Assessment Program RCT—randomized, controlled trial CPAP—continuous positive airway pressure IVH—intraventricular hemorrhage
Advanced technology in the treatment of preterm infants has resulted in decreasing mortality rates.1–3 Follow-up studies, however, have shown either an unchanging or an increased incidence of physical disabilities, developmental delays, and learning or behavioral and/or attention-deficit/hyperactivity disorders.1,2,4,5 Because preterm infants cannot regulate incoming stimuli, they become easily overstimulated and stressed, which can lead to hypoxemia, apnea, and variations in blood pressure. Als et al6–8 proposed a sensory mismatch of the expectations of preterm infant's developing nervous system for environmental inputs and the actual sensory overload that is experienced in the NICU. This in turn can lead to a greater chance for later developmental problems. To prevent these secondary consequences, several investigators have begun to focus on ways to improve the NICU environment for infants and parents through the use of developmental care (DC) programs.
Most research has been based on the Newborn Individualized Developmental Care Program (NIDCAP), which is a comprehensive approach in which caregiving is based on the individual behavior of the infant.8 A meta-analysis by Jacobs et al9 concluded that the evidence showing a positive effect from the NIDCAP program is inconclusive, and they recommended additional studies with a larger sample size, long-term follow-up, and the inclusion of cost-effectiveness evaluations. A Cochrane review10 evaluated the effects of various elements of DC (positioning, clustering of nursery care activities, and modification of external stimuli) as well as the NIDCAP individualized DC approach. Although there was evidence of limited benefits of DC interventions and no major harmful effects reported, there were a large number of outcomes with no or conflicting results. The single DC trials that did show a significant effect of an intervention on a major clinical outcome were based on small sample sizes, and the findings were often not supported in other small trials. More randomized trials were recommended in which the effectiveness of DC programs can be evaluated. No studies have been conducted to examine a less intensive, more basic DC program. The aim of this randomized, controlled trial (RCT) was to explore in preterm infants the effectiveness of the implementation of elements of basic DC to reduce stress and improve physiologic stability on neonatal morbidity, neuromotor development, and growth at term age.
| METHODS |
|---|
|
|
|---|
The intervention included the reduction of light and sound through the use of standardized incubator covers and supporting motor development and physiologic stability by positioning the infant in ways that encourage flexion and containment through the use of standardized nests and positioning aids. Infants in the control group received standard care, which at that time consisted of no covers or nesting. The ethical committees of both locations approved the study.
Definitions
Severity of illness was analyzed by using the Clinical Risk Index for Babies score, which assesses initial neonatal risk. Scores are given for birth weight, gestational age, maximum and minimum fraction of inspired oxygen and maximum base excess during the first 12 hours, and the presence of congenital malformation.11 Inborn infants were infants who were born in the participating tertiary neonatal center.
The primary medical outcome variables included duration of respiratory support, number of days in intensive care, and short-term growth. Mechanical ventilation and/or continuous positive airway pressure (CPAP) was measured in days. When an infant received both mechanical ventilation and CPAP in 1 day, the method of respiratory support given for the most hours was chosen. In addition, the total number of days of respiratory support was defined as total combined days of mechanical ventilation and CPAP. Discharge from the NICU was based on 2 criteria: the infant required no mechanical ventilation and/or CPAP for 24 hours and weighed at least 1000 g.
Infants were weighed at least biweekly; head circumference and length were measured within the first 2 days of life and thereafter weekly by trained medical students until the infant was either transferred or discharged. Short-term growth (weight, head circumference, and length) was defined as measurement at birth and at term age as well as mean daily weight gain in grams and mean weekly length and head-circumference growth in centimeters. Weight was measured on neonatal pediatric digital scales; length was measured from crown to heel; and head circumference was measured around the largest area of the head, occipital-frontal circumference, using a nonstretch tape measure.
In addition, secondary outcomes were analyzed. Mortality was defined as early neonatal death when the infant died within the first 7 days of life and late neonatal death when the infant died after 7 days but before 28 days of life. Days of oxygen were calculated as total days of supplementary oxygen as well as the need for oxygen after 28 days of life.
Bronchopulmonary dysplasia was defined as oxygen dependence at 36 weeks postconceptional age according to the criteria of Shennan et al.12 Postnatal steroids were divided into 3 classifications: 7 to 10, 15 to 20, and >20 days. Intraventricular hemorrhage (IVH) was recorded according to Volpe.13 Periventricular leukomalacia was classified according to grades 1 to 4.14 Sepsis was based on a positive blood culture (congenital infections excluded). Meningitis was defined as a positive cerebrospinal fluid culture and/or pleocytosis. In addition, the incidence of necrotizing enterocolitis, patent ductus arteriosus, retinopathy of prematurity, need for treatment of hypotension, and hyperbilirubinemia was analyzed.
Follow-up
At term age, infants were seen in the follow-up clinics to assess growth, morbidity, and neuromotor development by neonatologists who were experienced in developmental assessments and blinded to the group assignment of the infant. A standardized neurologic examination according to Prechtl15 was administered and was defined as definitely abnormal, mildly abnormal, or normal. Definitely abnormal means the presence of a full-blown neonatal neurologic syndrome, such as apathy or hyperexcitability, hypotonia or hypertonia, hyporeflexia or hyperreflexia, hypokinesia or hyperkinesia, or a hemisyndrome. Mildly abnormal denotes the presence of only part of such a syndrome. Examples of minor neurologic signs are abnormal posture, abnormal head control, and absent or abnormal responses or reflexes.
Statistical Analysis
Data were analyzed by using SPSS 12.0 for Windows (SPSS Inc, Chicago, IL). The infant and parent characteristics were compared with the
2 test, the
2 test for trend, or the 2-sample t test, where appropriate. Outcome parameters were compared between the 2 treatment groups with the t, Mann-Whitney, or
2 test where appropriate. A P value of <.05 was considered significant. Linear regression was used to evaluate the influence of the duration of the intervention on term age outcomes by testing whether there was an interaction effect between the intervention duration and the 2 treatment groups.
| RESULTS |
|---|
|
|
|---|
|
|
|
Primary Outcomes
No significant difference was found in the number of intensive care days, days of respiratory support, or growth between the DC and control groups (Table 3). Eighty-six (94.5%) infants in the DC group and 79 (89.8%) infants in the control group required some form of respiratory support. A total of 149 infants (DC: 76; control: 73) of the surviving 159 (93.7%) infants were seen at the follow-up clinic at term age. One infant was too ill to undergo a Prechtl examination. No significant difference was found in the neurologic outcomes between the DC and control groups. Of the 149 infants, 4 in the DC group and 3 in the control group were not measured or weighed at term age. Four surviving infants (DC: 3; control: 1) who had a diagnosis of posthemorrhagic ventricular dilation were excluded from the weekly and term age head-circumference analysis. No significant difference was found between the DC and control groups in the growth parameters at term age or in daily weight gain (g) and weekly length and head-circumference (cm) growth.
|
Secondary Outcomes
A total of 15 (19.2%) of 78 infants in the DC group required oxygen after 28 days of life as opposed to 22 (29.3%) of 75 infants in the control group; however, the difference was not significant (P = .15). No difference was found in the incidence of bronchopulmonary dysplasia between the 2 groups. In total 4 (4.4%) of 91 infants in the DC group required postnatal corticosteroids as opposed to 10 (11.4%) of 88 infants in the control group (P = .08). A total of 19 (20.9%) of 91 infants in the DC group had grade 1 or 2 IVH as opposed to 28 (31.8%) of 88 in the control group, and twice as many infants (11 of 91 [12.1%]) in the DC group had grade 3 IVH or grade 3 IVH and periventricular echodensity than in the control group (5 of 88 [5.7%]; P = .12). At term age, there was no difference in the incidence of periventricular leukomalacia or the number of infants who required physical therapy. Also, no significant differences were found in the remaining secondary outcomes (Table 4).
|
| DISCUSSION |
|---|
|
|
|---|
The Cochrane Review10 examined 4 separate DC interventions (positioning, clustering of care, modification of external stimuli, and individualized DC), but no studies that combined nesting, positioning aids, and incubator covers have been published to our knowledge. Because NICUs may start with these basic elements when embarking on the implementation of a DC program, we believed that it was important to study the effects of these basic interventions. Most previous RCTs examined the effects of the more intensive, individually focused NIDCAP, and although a few of them showed positive results,16–21 we were not able to duplicate this with the less intensive basic DC.
One limitation of our study was the variation in total days of hospital admission of studied infants. In the Netherlands neonatal care system, infants may be transferred to regional hospitals once they no longer require intensive care. This was also the case with a number of infants in our study. This would not affect the short-term outcomes such as days of intensive care or respiratory support, because all infants remained in the participating hospitals during this period, but could have an effect on growth and secondary outcomes at term age. If this were true, then infants who received more days of DC would show less morbidity and better short-term growth and neurodevelopmental outcomes; however, our analysis showed that this was not the case. It seems that at least concerning short-term outcomes, the duration of providing basic DC, whether only during the intensive care period or continuing DC until hospital discharge, has no significant effect.
The infants were randomly assigned in an appropriate manner; however, there could be no blinding of the intervention because the infants in the DC group had incubator covers and nesting. This did make it easier to ensure a strict control group whereby control infants were not provided with any nesting or incubator covers, because this was the standard method of care when this trial began and so was easy to maintain during the study period. The amount of respiratory support given to an infant was decided on by several neonatologists and so was not influenced by the study group in which the infant was placed. Because the discharge from the NICU was based on 2 criteria—the infant's requiring no mechanical ventilation and/or CPAP for 24 hours and weight at least 1000 g—intensive care days also could not be influenced by group participation. In addition, the neonatologists who performed the term age assessments were blinded to group participation.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
We thank Sylvia M. van der Pal, PhD (Leiden University Medical Center) for contribution to this research project.
| FOOTNOTES |
|---|
Address correspondence to Sylvia Veen, MD, PhD, Department of Pediatrics, J-6-S, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands. E-mail: s.veen{at}lumc.nl
The authors have indicated they have no financial relationships relevant to this article to disclose.
This trial has been registered at www.trialregister.nl (identifier ISRCTN84995192).
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||